SCHEMBL4115246

SCHEMBL4115246

OCc1c(-c2cccnc2)ccc2c(CCC3CCNCC3)noc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.36
PIM1 P11309 2/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
ALOX15 P16050 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ACHE P22303 2/20 0.35
BCHE P06276 1/20 0.35
CYP2A6 P11509 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4132482 0.91 ACHE (0.41) RAB9AL3MBTL1ACHEBCHESLC6A4
SCHEMBL4112442 0.89 KDM4E (0.35) KDM1APIM1USP2ALDH1A1CYP1A2
SCHEMBL4133580 0.84 ACHE (0.39) ACHEBCHE
SCHEMBL4125390 0.83 ACHE (0.40) ACHEBCHE
SCHEMBL4112092 0.83 ACHE (0.42) KDM1ACYP1A2HSD17B10MAOBACHE
SCHEMBL4114200 0.80 GPR119 (0.46) KDM1AKDM4EACHE
SCHEMBL4126816 0.79 ACHE (0.39) ALDH1A1RAB9AL3MBTL1ACHEBCHE
SCHEMBL4125646 0.78 TSHR (0.34) KDM1AACHEBCHEMAPK1HRH3
Hydrochloric Acid SCHEMBL4116872 0.78 TSHR (0.34) KDM1AACHEBCHEMAPK1HRH3
SCHEMBL13596010 0.76 ACHE (0.46) ACHEBCHEHRH3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 KDM1A 1437/4885PIM1 3069/4885USP2 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.